Houston Methodist Cancer Research Update August 2025

Houston Methodist Cancer Research Update – August 2025

Advancing Cancer Research with Houston Methodist & Golfers Against Cancer

Impact Report from Houston Methodist. 

“We are immensely grateful for your continued generosity which provides crucial support for our investigators to pursue promising new therapies and bring them closer to clinical use. We appreciate the dedication and hard work of so many volunteers who raise these funds. Our appreciation to Golfer’s Against Cancer members and your commitment in supporting cancer research at Houston Methodist.

Our team is pleased to present you with updates from the following projects:

  • A Highly Sensitive Non-Invasive Marker for Cancer Immunotherapy – Zejuan Li, MD, PhD

  • Targeting NR4A in GBM – Robert Rostomily, MD

  • Validating a New Drug to Block Cancer Metastasis – Kyuson Yun, PhD

 

We hope that you, along with all the supporters of Golfers Against Cancer, accept our heartfelt gratitude for all that you do for our patients and our community.

Have a blessed and peaceful evening.

With gratitude,

Cecilia”

 

 

Houston Methodist. Leading Medicine.

Houston Methodist Hospital has been named the Best Hospital in Texas for patient care and quality for the 14th year in a row by U.S. News & World Report. We are proud to be a top-ranked hospital in the country, and nationally ranked in 10 specialties. For more than 100 years, we have been honored to provide you with the highest quality care possible. That’s the difference between practicing medicine and leading it. For you.

Previous
Previous

September is Childhood Cancer Awareness Month

Next
Next

Golfer’s Against Cancer’s Impact on MD Anderson Cancer Center by the Numbers